Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma

被引：0
|
作者：
Ahmad Joshkon
Emeline Tabouret
Wael Traboulsi
Richard Bachelier
Stéphanie Simoncini
Sandrine Roffino
Carine Jiguet-Jiglaire
Bassam Badran
Benjamin Guillet
Alexandrine Foucault-Bertaud
Aurelie S. Leroyer
Françoise Dignat-George
Olivier Chinot
Hussein Fayyad-Kazan
Nathalie Bardin
Marcel Blot-Chabaud
机构：
[1] Aix-Marseille University,Department of Neuro
[2] INSERM1263,Oncology
[3] INRAE1260,Laboratory of Cancer Biology and Molecular Immunology, Faculty of Science
[4] C2VN,Department of Radiopharmacy
[5] Aix-Marseille University,undefined
[6] APHM,undefined
[7] CNRS,undefined
[8] INP,undefined
[9] Service de Neuro-Oncologie CHU Timone,undefined
[10] Hôpitaux de Marseille,undefined
[11] CNRS,undefined
[12] ISM UMR 7287,undefined
[13] Aix-Marseille University,undefined
[14] Lebanese University,undefined
[15] La Timone University Hospital,undefined
[16] CERIMED,undefined
[17] Aix-Marseille University,undefined
来源：
Acta Neuropathologica Communications | / 10卷
关键词：
Soluble CD146; Biomarker; Therapeutic antibody; Bevacizumab; Glioblastoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Essence of resistance to anti-angiogenic therapy in tumors
    Chen Zhong-ping
    CHINESE MEDICAL JOURNAL, 2011, 124 (24) : 4363 - 4363
  • [22] Essence of resistance to anti-angiogenic therapy in tumors
    CHEN Zhongping State Key Laboratory of Oncology in South China and Department of NeurosurgeryNeuroOncologyCancer CenterSun Yatsen University GuangzhouGuangdong China
    中华医学杂志(英文版), 2011, (24) : 4363 - 4363
  • [23] Obesity associated with resistance to anti-angiogenic therapy
    David Killock
    Nature Reviews Clinical Oncology, 2018, 15 (6) : 344 - 344
  • [24] Autophagy as a mechanism for anti-angiogenic therapy resistance
    Chandra, Ankush
    Rick, Jonathan
    Yagnik, Garima
    Aghi, Manish K.
    SEMINARS IN CANCER BIOLOGY, 2020, 66 : 75 - 88
  • [25] Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
    Jeon, Hanwool
    Byun, Joonho
    Kang, Hayeong
    Kim, Kyunggon
    Lee, Eunyeup
    Kim, Jeong Hoon
    Hong, Chang Ki
    Song, Sang Woo
    Kim, Young-Hoon
    Chong, Sangjoon
    Kim, Jae Hyun
    Nam, Soo Jeong
    Park, Ji Eun
    Lee, Seungjoo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [26] Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
    Hanwool Jeon
    Joonho Byun
    Hayeong Kang
    Kyunggon Kim
    Eunyeup Lee
    Jeong Hoon Kim
    Chang Ki Hong
    Sang Woo Song
    Young-Hoon Kim
    Sangjoon Chong
    Jae Hyun Kim
    Soo Jeong Nam
    Ji Eun Park
    Seungjoo Lee
    Journal of Translational Medicine, 21
  • [27] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Yasushi Soda
    Chad Myskiw
    Amy Rommel
    Inder M. Verma
    Journal of Molecular Medicine, 2013, 91 : 439 - 448
  • [28] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Soda, Yasushi
    Myskiw, Chad
    Rommel, Amy
    Verma, Inder M.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (04): : 439 - 448
  • [29] γ-secretase is new therapeutic target for anti-angiogenic therapy
    Hayashi, Hiroki
    Nakagami, Hironori
    Saito, Yukihiro
    Talkami, Yoichi
    Nishikawa, Tomoyuki
    Sato, Naoyuki
    Morishita, Ryuichi
    Kaneda, Yasufumi
    HYPERTENSION, 2006, 48 (04) : E94 - E94
  • [30] Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
    Zhang, Ashley B. B.
    Mozaffari, Khashayar
    Aguirre, Brian
    Li, Victor
    Kubba, Rohan
    Desai, Nilay C.
    Wei, Darren
    Yang, Isaac
    Wadehra, Madhuri
    CANCERS, 2023, 15 (03)
12345